EP Wealth Advisors LLC Increases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

EP Wealth Advisors LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,533 shares of the exchange traded fund’s stock after purchasing an additional 518 shares during the quarter. EP Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $498,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. EPG Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 37.5% in the fourth quarter. EPG Wealth Management LLC now owns 916 shares of the exchange traded fund’s stock valued at $83,000 after purchasing an additional 250 shares during the period. Blackstone Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 107.6% in the fourth quarter. Blackstone Inc. now owns 211,840 shares of the exchange traded fund’s stock valued at $19,078,000 after purchasing an additional 109,810 shares during the period. Captrust Financial Advisors grew its holdings in shares of SPDR S&P Biotech ETF by 31.1% in the fourth quarter. Captrust Financial Advisors now owns 23,935 shares of the exchange traded fund’s stock valued at $2,156,000 after purchasing an additional 5,683 shares during the period. Cary Street Partners Financial LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $566,000. Finally, Baird Financial Group Inc. boosted its stake in SPDR S&P Biotech ETF by 9.5% during the fourth quarter. Baird Financial Group Inc. now owns 66,510 shares of the exchange traded fund’s stock worth $5,990,000 after buying an additional 5,759 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $76.39 on Monday. The firm has a market cap of $4.85 billion, a PE ratio of 11.47 and a beta of 1.00. The company has a 50-day moving average of $80.77 and a two-hundred day moving average of $89.16. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.